Optellum Ltd is a company based in Oxford, United Kingdom, specializing in the development of AI-driven clinical decision support software for lung cancer diagnosis and treatment. Founded in 2015, Optellum aims to enhance cancer care by providing an end-to-end IT platform that facilitates personalized early diagnosis and therapeutic strategies for patients at high risk of developing lung cancer, which is the most common and deadliest form of cancer. The company's innovative software identifies at-risk individuals and streamlines optimal treatment options, leveraging machine learning to analyze vast datasets from numerous healthcare professionals. Optellum's team consists of experts in medical imaging, artificial intelligence, and clinical practice, many of whom have a history of successful innovations in the medical technology sector. They are supported by an advisory board of leading clinicians and deep learning specialists, and are actively expanding their product development team to further their mission in the fight against cancer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.